middle.news
How Island Pharmaceuticals’ Texas Biomed Deal Could Accelerate Galidesivir Approval
8:44am on Wednesday 17th of December, 2025 AEDT
•
Pharmaceuticals
Read Story
How Island Pharmaceuticals’ Texas Biomed Deal Could Accelerate Galidesivir Approval
8:44am on Wednesday 17th of December, 2025 AEDT
Key Points
Master Service Agreement signed with Texas Biomedical Research Institute
Access to BSL-4 containment and National Primate Research Centre capabilities
Supports non-human primate studies critical for FDA Animal Rule approval
Recent FDA feedback confirms eligibility for Priority Review Voucher
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE